Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.

The Oncology Institute, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

CERRITOS, CALIF., AUG. 13, 2025 (GLOBE NEWSWIRE) -- THE ONCOLOGY INSTITUTE, INC. (NASDAQ: TOI) (TOI OR THE COMPANY), ONE OF THE LARGEST VALUE-BASED COMMUNITY ONCOLOGY GROUPS IN THE UNITED STATES, TODAY REPORTED FINANCIAL RESULTS FOR ITS THREE MONTHS ENDED JUNE30, 2025.

THE ONCOLOGY INSTITUTE REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND REAFFIRMS FULL YEAR 2025 GUIDANCE

RICHARD BARASCH TO RETIRE; ANNE MCGEORGE BRINGS EXTENSIVE FINANCIAL EXPERIENCE TO ROLE AS NEW CHAIRMAN RICHARD BARASCH TO RETIRE; ANNE MCGEORGE BRINGS EXTENSIVE FINANCIAL EXPERIENCE TO ROLE AS NEW CHAIRMAN

THE ONCOLOGY INSTITUTE ANNOUNCES CHANGES TO BOARD OF DIRECTORS

TORONTO, AUG. 01, 2025 (GLOBE NEWSWIRE) -- TOPICUS.COM INC. (TSXV:TOI) IN A JOINT RELEASE WITH CONSTELLATION SOFTWARE INC. (TSX:CSU) TODAY ANNOUNCED FINANCIAL RESULTS FOR TOPICUS.COM INC. (TOPICUS OR THE COMPANY) FOR THE SECOND QUARTER ENDED JUNE 30, 2025. PLEASE NOTE THAT ALL AMOUNTS REFERRED TO IN THIS PRESS RELEASE ARE IN EUROS UNLESS OTHERWISE STATED.

CONSTELLATION SOFTWARE INC. AND TOPICUS.COM INC. ANNOUNCE RESULTS FOR TOPICUS.COM INC. FOR THE SECOND QUARTER ENDED JUNE 30, 2025

TORONTO, JULY 14, 2025 (GLOBE NEWSWIRE) -- TOPICUS.COM INC. (TSXV:TOI) ANNOUNCED TODAY IT INTENDS TO RELEASE ITS SECOND QUARTER RESULTS ON AUGUST 1, 2025.

TOPICUS.COM INC. ANNOUNCES RELEASE DATE FORSECOND QUARTER RESULTS

CERRITOS, CALIF., JULY 14, 2025 (GLOBE NEWSWIRE) -- THE ONCOLOGY INSTITUTE, INC. (NASDAQ: TOI) (TOI), ONE OF THE LARGEST VALUE-BASED ONCOLOGY GROUPS IN THE UNITED STATES, ANNOUNCED TODAY THAT KRISTIN ENGLAND HAS JOINED THE ORGANIZATION AS CHIEF ADMINISTRATIVE OFFICER (CAO), EFFECTIVE JULY 7, 2025. IN THIS NEWLY ESTABLISHED ROLE, ENGLAND WILL OVERSEE ENTERPRISE CENTRAL BUSINESS OPERATIONS AND TECHNOLOGY STRATEGY AND ENABLEMENT ACROSS TOI'S EXPANDING NATIONAL FOOTPRINT.

THE ONCOLOGY INSTITUTE NAMES KRISTIN ENGLAND AS CHIEF ADMINISTRATIVE OFFICER

CERRITOS, CALIF., JUNE 30, 2025 (GLOBE NEWSWIRE) -- THE ONCOLOGY INSTITUTE, INC. (NASDAQ: TOI) (TOI), ONE OF THE LARGEST VALUE-BASED ONCOLOGY GROUPS IN THE UNITED STATES, ANNOUNCED TODAY THAT EFFECTIVE JULY 1, IT WILL BE THE EXCLUSIVE ONCOLOGY PROVIDER FOR OVER 80,000 MEDICAID PATIENTS ASSOCIATED WITH SILVERSUMMIT HEALTHPLAN IN NEVADA. TOI IS KNOWN FOR BRINGING STATE-OF-THE-ART CANCER CARE TO THE COMMUNITIES IT SERVES, AND THEIR PRESENCE IN THE LAS VEGAS MARKET WILL PROVIDE ENHANCED ACCESS TO CARE AND HIGH-LEVEL SERVICES TO THE IMPORTANT MEDICAID POPULATION HERE.

THE ONCOLOGY INSTITUTE AND SILVERSUMMIT HEALTHPLAN PARTNER TO PROVIDE ONCOLOGY CARE TO OVER 80,000 MEDICAID MEMBERS IN NEVADA

TORONTO, JUNE 30, 2025 (GLOBE NEWSWIRE) -- TOPICUS.COM INC. (THE CORPORATION) (TSXV: TOI) TODAY ANNOUNCED THAT ITS SUBSIDIARY, TOPICUS.COM COPERATIEF U.A., HAS SUCCESSFULLY OBTAINED A 200 MILLION SENIOR UNSECURED SCHULDSCHEIN LOAN. THE SCHULDSCHEIN LOAN WAS INITIALLY LAUNCHED AT 100 MILLION AND WAS SUBSEQUENTLY DOUBLED ON THE BACK OF SIGNIFICANT INTEREST FROM INSTITUTIONAL LENDERS. THE SCHULDSCHEIN LOAN IS STRUCTURED IN SEVERAL TRANCHES AT VARIABLE RATES, WITH 79.5 MILLION MATURING IN 3 YEARS, 105.5 MILLION MATURING IN 5 YEARS AND 15 MILLION MATURING IN 7 YEARS.

TOPICUS.COM INC. SUCCESSFULLY COMPLETES INAUGURAL 200 MILLION SCHULDSCHEIN LOAN

CERRITOS, CALIF., JUNE 03, 2025 (GLOBE NEWSWIRE) -- THE ONCOLOGY INSTITUTE, INC. (NASDAQ: TOI) (TOI), ONE OF THE LARGEST VALUE-BASED ONCOLOGY GROUPS IN THE UNITED STATES, TODAY ANNOUNCED THAT IT WILL JOIN THE RUSSELL 2000 AND RUSSELL 3000 AFTER THE 2025 RUSSELL INDEXES ANNUAL RECONSTITUTION, EFFECTIVE AFTER THE US MARKET CLOSES ON JUNE 27, ACCORDING TO A PRELIMINARY LIST OF ADDITIONS POSTED ON MAY 23.

THE ONCOLOGY INSTITUTE SET TO JOIN THE RUSSELL 2000 AND RUSSELL 3000 INDEXES

CERRITOS, CALIF., MAY 14, 2025 (GLOBE NEWSWIRE) -- THE ONCOLOGY INSTITUTE, INC. (NASDAQ: TOI) (TOI), ONE OF THE LARGEST VALUE-BASED ONCOLOGY GROUPS IN THE UNITED STATES, ANNOUNCED TODAY THAT DR. JEFFREY LANGSAM WILL ASSUME THE ROLE OF ENTERPRISE CHIEF CLINICAL OFFICER EFFECTIVE MAY 13TH, 2025. THE CCO ROLE WILL OVERSEE THERAPEUTICS INCLUDING PATHWAY AND PROCUREMENT DECISIONS, UTILIZATION MANAGEMENT, AND MSO PRACTICE CLINICAL ENGAGEMENT. DR. LANGSAM JOINS TOI FROM CIGNA HEALTHCARE, WHERE HE WAS THE NATIONAL DIRECTOR OF ONCOLOGY AND A SENIOR MEDICAL DIRECTOR IN THE SPECIALTY PHARMACY DIVISION. HE PREVIOUSLY SERVED AS A REGIONAL MEDICAL DIRECTOR AT AETNA, AND WAS CLINICAL FACULTY AT THE UNIVERSITY OF CONNECTICUT WHERE HE WAS A PRACTICING ONCOLOGIST FOR MANY YEARS.

THE ONCOLOGY INSTITUTE WELCOMES DR. JEFF LANGSAM AS CHIEF CLINICAL OFFICER

TORONTO, MAY 13, 2025 (GLOBE NEWSWIRE) -- TOPICUS.COM INC. (TOPICUS OR THE CORPORATION) (TSXV: TOI) IS PLEASED TO ANNOUNCE THE ELECTION OF EACH OF THE FIVE DIRECTOR NOMINEES LISTED IN THE CORPORATION'S MANAGEMENT PROXY CIRCULAR DATED MARCH 28, 2025, JOHN BILLOWITS, ALEX MACDONALD, LORI O'NEILL, DONNA PARR AND ROBIN VAN POELJE, TO THE CORPORATION'S BOARD OF DIRECTORS AT ITS MAY 13, 2025 ANNUAL GENERAL MEETING OF SHAREHOLDERS (THE AGM).

TOPICUS.COM INC. ANNOUNCES ELECTION OF MEMBERS OF THE BOARD OF DIRECTORS

CERRITOS, CALIF., MAY 13, 2025 (GLOBE NEWSWIRE) -- THE ONCOLOGY INSTITUTE, INC. (NASDAQ: TOI) (TOI), ONE OF THE LARGEST VALUE-BASED ONCOLOGY GROUPS IN THE UNITED STATES, TODAY ANNOUNCED THAT DR. DANIEL VIRNICH, CHIEF EXECUTIVE OFFICER, AND ROB CARTER, CHIEF FINANCIAL OFFICER, WILL PARTICIPATE IN B. RILEY'S 25TH ANNUAL INSTITUTIONAL INVESTOR CONFERENCE IN MARINA DEL REY, CA ON MAY 21ST, 2025.

THE ONCOLOGY INSTITUTE TO PARTICIPATE AT THE B. RILEY SECURITIES 25TH ANNUAL INSTITUTIONAL INVESTOR CONFERENCE

TORONTO, MAY 07, 2025 (GLOBE NEWSWIRE) -- TOPICUS.COM INC. (TSXV:TOI) IN A JOINT RELEASE WITH CONSTELLATION SOFTWARE INC. (TSX:CSU) TODAY ANNOUNCED FINANCIAL RESULTS FOR TOPICUS.COM INC. (TOPICUS OR THE COMPANY) FOR THE FIRST QUARTER ENDED MARCH 31, 2025. PLEASE NOTE THAT ALL AMOUNTS REFERRED TO IN THIS PRESS RELEASE ARE IN EUROS UNLESS OTHERWISE STATED.

The Oncology Institute, Inc.

TOI

Price

Financials Overview

Financial Reports

No items found.

Press Releases

The Oncology Institute, Inc.

TOI.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

TOI